Claritin /00917501/


Indications and Reactions:

Role Indications Reactions
Secondary
Asthma 27.3%
Drug Use For Unknown Indication 27.3%
Hypertension 18.2%
Arthralgia 9.1%
Cerebral Infarction 9.1%
Cholelithiasis 9.1%
Tubulointerstitial Nephritis 50.0%
Vasculitis 50.0%
Concomitant
Product Used For Unknown Indication 48.7%
Premedication 8.1%
Pain 5.2%
Hypertension 4.5%
Hypersensitivity 4.1%
Gout 3.2%
Multiple Myeloma 2.7%
Paroxysmal Nocturnal Haemoglobinuria 2.5%
Prophylaxis 2.5%
Depression 2.4%
Insomnia 2.1%
Diabetes Mellitus 1.8%
Rheumatoid Arthritis 1.8%
Nausea 1.7%
Seasonal Allergy 1.7%
Asthma 1.6%
Angiogram 1.5%
Hypothyroidism 1.4%
Constipation 1.3%
Anxiety 1.2%
Vomiting 13.8%
Infusion Related Reaction 8.5%
Somnolence 8.5%
Weight Increased 7.4%
Injection Site Pain 5.3%
Weight Decreased 5.3%
Death 4.3%
Drug Ineffective 4.3%
Pneumonitis 4.3%
Tremor 4.3%
Type Iv Hypersensitivity Reaction 4.3%
Urticaria 4.3%
Diarrhoea 3.2%
Granulocytopenia 3.2%
Incorrect Dose Administered 3.2%
Neuralgic Amyotrophy 3.2%
Pain 3.2%
Pneumonia 3.2%
Pruritus 3.2%
Psoriasis 3.2%

Drug Data